Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management

Mohammed Obeidat, Malcolm Burgess, Gregory Y. H. Lip*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

1 Citationer (Scopus)

Abstract

Heart failure (HF) and atrial fibrillation (AF), increasingly common in the aging population, are closely related and commonly found together. This article explores the relationship between AF and HF and the thromboembolic effect of these diseases. Morbidity and mortality are increased when the 2 conditions are seen together. Stroke risks are significant with AF and all subtypes of HF. This article suggests that all patients with AF and HF should be considered for anticoagulation. Current evidence suggests that non-vitamin K antagonist oral anticoagulants are effective and safe in AF and HF in comparison with warfarin.

OriginalsprogEngelsk
TidsskriftCardiology Clinics
Vol/bind40
Udgave nummer2
Sider (fra-til)245-258
Antal sider14
ISSN0733-8651
DOI
StatusUdgivet - maj 2022

Bibliografisk note

Copyright © 2021 Elsevier Inc. All rights reserved.

Denne artikel udkom originalt i Heart Failure Clinics, Volume 16, Issue 1, Januar 2020.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management'. Sammen danner de et unikt fingeraftryk.

Citationsformater